Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center study

Type 1 diabetes mellitus (DM) and rheumatoid arthritis (RA) have been reported to occur concurrently in some cases. This study aimed to evaluate the presence of anti-cyclic citrullinated peptide (CCP) antibodies, which have been reported to have diagnostic value for RA, in children with type...

Full description

Saved in:
Bibliographic Details
Main Authors: Melek Yıldız, Figen İşleten, Korcan Demir, Nilüfer Çelik, Hüseyin Anıl Korkmaz, Birsen Tuğlu, Özlem Nalbantoğlu, Behzat Özkan
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2016-08-01
Series:The Turkish Journal of Pediatrics
Subjects:
Online Access:https://turkjpediatr.org/article/view/1131
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025326902509568
author Melek Yıldız
Figen İşleten
Korcan Demir
Nilüfer Çelik
Hüseyin Anıl Korkmaz
Birsen Tuğlu
Özlem Nalbantoğlu
Behzat Özkan
author_facet Melek Yıldız
Figen İşleten
Korcan Demir
Nilüfer Çelik
Hüseyin Anıl Korkmaz
Birsen Tuğlu
Özlem Nalbantoğlu
Behzat Özkan
author_sort Melek Yıldız
collection DOAJ
description Type 1 diabetes mellitus (DM) and rheumatoid arthritis (RA) have been reported to occur concurrently in some cases. This study aimed to evaluate the presence of anti-cyclic citrullinated peptide (CCP) antibodies, which have been reported to have diagnostic value for RA, in children with type 1 DM. The study included 90 children with type 1 DM (Group 1) and 76 control cases (Group 2). The rates of reported family histories of RA and rheumatoid factor positivity did not differ between groups. In group 1, one case (1.1%) was positive for anti-CCP antibodies, whereas none of the controls were positive. The anti-CCP positive patient had no relevant joint complaints. Anti-CCP antibodies were rarely found in cases of pediatric type 1 DM. Thus, relevant screening in the follow-up of pediatric patients does not appear to be rational in the absence of any signs or symptoms of arthritis. The single case exhibiting a high anti-CCP level needs to be followed up for RA, although this positive result might be nonspecific and transient.
format Article
id doaj-art-edee55d12cc44515bf08b86e40bc540d
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2016-08-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-edee55d12cc44515bf08b86e40bc540d2025-08-20T03:00:53ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212016-08-0158410.24953/turkjped.2016.04.008Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center studyMelek Yıldız0Figen İşleten1Korcan Demir2Nilüfer Çelik3Hüseyin Anıl Korkmaz4Birsen Tuğlu5Özlem Nalbantoğlu6Behzat Özkan7Divisions of Pediatric Endocrinology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.Divisions of Biochemistry, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.Divisions of Pediatric Endocrinology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.Divisions of Biochemistry, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.Divisions of Pediatric Endocrinology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.Divisions of Biochemistry, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.Divisions of Pediatric Endocrinology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey.Divisions of Pediatric Endocrinology, Dr. Behçet Uz Children's Hospital, Izmir, Turkey. Type 1 diabetes mellitus (DM) and rheumatoid arthritis (RA) have been reported to occur concurrently in some cases. This study aimed to evaluate the presence of anti-cyclic citrullinated peptide (CCP) antibodies, which have been reported to have diagnostic value for RA, in children with type 1 DM. The study included 90 children with type 1 DM (Group 1) and 76 control cases (Group 2). The rates of reported family histories of RA and rheumatoid factor positivity did not differ between groups. In group 1, one case (1.1%) was positive for anti-CCP antibodies, whereas none of the controls were positive. The anti-CCP positive patient had no relevant joint complaints. Anti-CCP antibodies were rarely found in cases of pediatric type 1 DM. Thus, relevant screening in the follow-up of pediatric patients does not appear to be rational in the absence of any signs or symptoms of arthritis. The single case exhibiting a high anti-CCP level needs to be followed up for RA, although this positive result might be nonspecific and transient. https://turkjpediatr.org/article/view/1131anti-cyclic citrullinated peptide antibodiesrheumatoid arthritistype 1 diabetes mellitus
spellingShingle Melek Yıldız
Figen İşleten
Korcan Demir
Nilüfer Çelik
Hüseyin Anıl Korkmaz
Birsen Tuğlu
Özlem Nalbantoğlu
Behzat Özkan
Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center study
The Turkish Journal of Pediatrics
anti-cyclic citrullinated peptide antibodies
rheumatoid arthritis
type 1 diabetes mellitus
title Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center study
title_full Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center study
title_fullStr Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center study
title_full_unstemmed Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center study
title_short Anti-cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus: a single-center study
title_sort anti cyclic citrullinated peptide antibodies are not frequently observed in children with type 1 diabetes mellitus a single center study
topic anti-cyclic citrullinated peptide antibodies
rheumatoid arthritis
type 1 diabetes mellitus
url https://turkjpediatr.org/article/view/1131
work_keys_str_mv AT melekyıldız anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy
AT figenisleten anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy
AT korcandemir anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy
AT nilufercelik anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy
AT huseyinanılkorkmaz anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy
AT birsentuglu anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy
AT ozlemnalbantoglu anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy
AT behzatozkan anticycliccitrullinatedpeptideantibodiesarenotfrequentlyobservedinchildrenwithtype1diabetesmellitusasinglecenterstudy